To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ATF5TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
458 supporting clones for gene ATF5 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA637525 Liver .a 1 to 553 2 to 555   tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
DB459564 testis .a 635 to 1119 1 to 485   tiling clone,   485/485
(100 %)
1 diff
(99.8 %id)
AL538073 brain, fetal brain .a 1002 to 1706 1 to 705       705/705
(100 %)
6 diff
(99.2 %id)
BQ940023 leiomyosarcoma, uterus .a 1017 to 1776 1 to 760   tiling clone,   760/858
(88 %)
19 diff
(97.8 %id)
BX355244 Neuroblastoma Cot 50-normalized .a 1021 to 1913 1 to 875   tiling clone,   875/914
(95 %)
38 diff
(95.9 %id)
BX441073 brain, fetal brain .a 1027 to 1701 1 to 675       675/675
(100 %)
3 diff
(99.6 %id)
BG339101 leiomyosarcoma cell line, uterus .a 1048 to 1602 20 to 594       575/985
(58 %)
24 diff
(97.6 %id)
Z43333 brain, total brain .a 1049 to 1253 1 to 206       206/206
(100 %)
3 diff
(98.6 %id)
AL538072 brain, fetal brain .a 2027 to 3014 983 to 1   tiling clone,   983/1050
(93 %)
22 diff
(98.0 %id)
BX333922 Neuroblastoma Cot 50-normalized .a 2059 to 2858 934 to 144   tiling clone,   791/1014
(78 %)
0 diff
(100 %id)
DB321232 Liver .a 2578 to 3030 464 to 11   tiling clone,   454/464
(97 %)
0 diff
(100 %id)
Z39409 brain, total brain .a 2629 to 2923 295 to 1       295/295
(100 %)
0 diff
(100 %id)
BP378116 uterus .b 1 to 581 1 to 579   tiling clone,   579/579
(100 %)
3 diff
(99.5 %id)
BF528888 anaplastic oligodendroglioma with 1p/19qloss, brain .b 13 to 623 7 to 618   tiling clone,   612/625
(97 %)
12 diff
(98.1 %id)
DA431738 colon .b 28 to 602 2 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA905115   .b 34 to 592 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
BI254100 cervical carcinoma cell line, cervix .b 36 to 628 1 to 600       600/603
(99 %)
22 diff
(96.4 %id)
BM549389 melanotic melanoma, skin .b 36 to 1060 13 to 1043       1031/1077
(95 %)
56 diff
(94.9 %id)
CN356173 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 38 to 727 1 to 692       692/692
(100 %)
7 diff
(99.0 %id)
DR007101 Spleen .b 42 to 609 17 to 584       568/584
(97 %)
6 diff
(99.0 %id)
BQ949639 large cell carcinoma, lung .b 54 to 864 1 to 818       818/944
(86 %)
29 diff
(97.0 %id)
BJ994243 hepatoblastoma .b 57 to 463 1 to 407       407/407
(100 %)
6 diff
(98.6 %id)
AB021663   .b 59 to 2068 1 to 2010 exact     2010/2010
(100 %)
3 diff
(99.9 %id)
AK024402   .b 59 to 1432 1 to 1374 exact available from FLJ,   1374/1374
(100 %)
3 diff
(99.8 %id)
BP225852   .b 59 to 638 1 to 582       582/582
(100 %)
8 diff
(98.7 %id)
DT215855 brain .b 59 to 694 1 to 635       635/635
(100 %)
5 diff
(99.3 %id)
BM547588 brain, hippocampus .b 59 to 815 9 to 776       768/1229
(62 %)
27 diff
(97.9 %id)
CB959788 Human Placenta, placenta .b 59 to 741 24 to 711       688/750
(91 %)
13 diff
(98.3 %id)
BJ992852.
matches multiple genes
hepatoblastoma .b 60 to 467 1 to 408     also hits gene CYP3A4andCYP3A7andCYP3A5P1 408/408
(100 %)
0 diff
(100 %id)
AU141087   .b 60 to 742 2 to 685   capped   684/685
(99 %)
6 diff
(99.2 %id)
DA048328   .b 61 to 605 2 to 546   capped   545/545
(100 %)
4 diff
(99.3 %id)
DA642714 Liver .b 61 to 627 2 to 568   capped   567/567
(100 %)
4 diff
(99.3 %id)
DA717346   .b 62 to 604 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
BM193312 leukopheresis .b 62 to 605 1 to 543       543/557
(97 %)
3 diff
(99.5 %id)
AB073613   .b 63 to 2069 1 to 2007 P121L tiling clone,   2007/2016
(99 %)
2 diff
(100.0 %id)
CR609432 fetal liver .b 63 to 1388 1 to 1326 exact     1326/1326
(100 %)
0 diff
(100 %id)
AL545471 placenta, Placenta Cot 25-normalized .b 63 to 836 1 to 770       770/933
(82 %)
26 diff
(97.3 %id)
AL580018 T cells from T cell leukemia .b 63 to 628 1 to 565       565/566
(99 %)
11 diff
(98.1 %id)
AL557743 T cells from T cell leukemia .b 63 to 786 1 to 721       721/721
(100 %)
19 diff
(97.4 %id)
BX344413   .b 63 to 1193 1 to 1125       1125/1131
(99 %)
31 diff
(97.3 %id)
AL557780 T cells from T cell leukemia .b 63 to 740 1 to 675       675/846
(79 %)
12 diff
(98.6 %id)
BX388029   .b 63 to 1025 1 to 953   fully sequenced,   953/953
(100 %)
32 diff
(96.7 %id)
AL531376 brain, fetal liver, Liver, neuroblastoma cells .b 63 to 779 1 to 714       714/716
(99 %)
22 diff
(97.0 %id)
BX447940 fetal liver, Liver .b 63 to 737 1 to 672       672/681
(98 %)
19 diff
(97.3 %id)
BX405697 fetal liver, Liver .b 63 to 742 1 to 678       678/678
(100 %)
12 diff
(98.3 %id)
BX448692 fetal liver, Liver .b 63 to 767 1 to 704       704/854
(82 %)
17 diff
(98.1 %id)
BX428016 fetal liver, Liver .b 63 to 737 1 to 672       672/672
(100 %)
29 diff
(95.7 %id)
BP225928   .b 63 to 632 1 to 573       573/576
(99 %)
8 diff
(98.7 %id)
DB457357 testis .b 63 to 524 1 to 462       462/462
(100 %)
10 diff
(97.9 %id)
BJ993003 hepatoblastoma .b 63 to 616 1 to 554       554/554
(100 %)
0 diff
(100 %id)
BJ995700 hepatoblastoma .b 63 to 471 1 to 409       409/409
(100 %)
2 diff
(99.6 %id)
CB109210 Liver .b 63 to 543 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
BP292880 lung .b 63 to 639 1 to 578       578/583
(99 %)
5 diff
(99.2 %id)
BP293109 lung .b 63 to 638 1 to 576       576/581
(99 %)
2 diff
(99.7 %id)
BM763064 myeloma .b 63 to 165 1 to 103       103/103
(100 %)
0 diff
(100 %id)
BM847399 myeloma .b 63 to 616 1 to 553       553/553
(100 %)
1 diff
(99.9 %id)
BM849192 myeloma .b 63 to 695 1 to 631       631/631
(100 %)
3 diff
(99.6 %id)
BP334898 salivary gland .b 63 to 638 1 to 580       580/582
(99 %)
16 diff
(97.3 %id)
BP344493 synovial membrane .b 63 to 562 1 to 493       493/582
(84 %)
18 diff
(97.0 %id)
DA018001 adrenal gland .b 64 to 640 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA037496   .b 64 to 614 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA051617   .b 64 to 612 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA383581 thalamus .b 64 to 635 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
DA482356   .b 64 to 631 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA584355 lung .b 64 to 613 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA598572   .b 64 to 620 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA598963   .b 64 to 623 2 to 561   capped   560/562
(99 %)
2 diff
(99.7 %id)
DA639578 Liver .b 64 to 604 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DA687165   .b 64 to 597 2 to 535   capped   534/535
(99 %)
2 diff
(99.7 %id)
DA699169   .b 64 to 590 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
DA705361   .b 64 to 574 2 to 512   capped   511/511
(100 %)
1 diff
(99.9 %id)
DA849798 placenta .b 64 to 622 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB199061 trachea .b 64 to 623 2 to 561   capped   560/565
(99 %)
1 diff
(99.9 %id)
DB270536 uterus .b 64 to 600 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
BE297910 muscle, rhabdomyosarcoma .b 66 to 492 16 to 445       430/595
(72 %)
10 diff
(98.4 %id)
DA637943 Liver .b 67 to 607 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BF205573 muscle, rhabdomyosarcoma .b 69 to 619 1 to 548       548/548
(100 %)
4 diff
(99.3 %id)
BG258074 embryonal carcinoma, cell line, testis .b 69 to 619 10 to 566       557/906
(61 %)
24 diff
(97.4 %id)
CN356177 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 71 to 619 1 to 550       550/550
(100 %)
2 diff
(99.7 %id)
CR592798 fetal liver .b 71 to 2051 1 to 1981 exact tiling clone,   1981/1981
(100 %)
0 diff
(100 %id)
BX426803 fetal liver, Liver .b 71 to 1006 1 to 928   fully sequenced,   928/928
(100 %)
31 diff
(96.7 %id)
BC005174 Placenta, choriocarcinoma .b 72 to 1432 1 to 1361 P121L available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1361/1361
(100 %)
2 diff
(99.9 %id)
BF304749 muscle, rhabdomyosarcoma .b 72 to 634 1 to 561       561/846
(66 %)
12 diff
(98.6 %id)
CN356175 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 73 to 605 12 to 544       533/544
(97 %)
6 diff
(98.9 %id)
BX448039 fetal liver, Liver .b 73 to 849 13 to 780       768/808
(95 %)
57 diff
(93.0 %id)
BF308693 muscle, rhabdomyosarcoma .b 74 to 632 1 to 560   AAA   560/666
(84 %)
4 diff
(99.4 %id)
BG470597 eye, retinoblastoma .b 74 to 629 1 to 556       556/570
(97 %)
5 diff
(99.2 %id)
TI_57178779   .b 74 to 631 34 to 590       557/591
(94 %)
7 diff
(98.9 %id)
CN356179 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 75 to 549 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
ES307722 beard hair, skin .b 75 to 232 1 to 158       158/158
(100 %)
2 diff
(98.8 %id)
BG389936 embryonal carcinoma, cell line, testis .b 75 to 616 1 to 543       543/973
(55 %)
5 diff
(99.5 %id)
BI254382 cervical carcinoma cell line, cervix .b 75 to 627 1 to 553       553/611
(90 %)
2 diff
(99.7 %id)
BI767103 pooled lung and spleen .b 75 to 631 1 to 556       556/557
(99 %)
2 diff
(99.7 %id)
BM464772 lymph, lymphoma, cell line .b 75 to 1005 1 to 946       946/1107
(85 %)
46 diff
(95.9 %id)
BM475881 eye, retinoblastoma .b 75 to 838 1 to 769       769/1091
(70 %)
10 diff
(99.1 %id)
CD624145   .b 76 to 623 1 to 549       549/549
(100 %)
4 diff
(99.3 %id)
CN356181 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 76 to 634 1 to 561       561/561
(100 %)
3 diff
(99.5 %id)
BX375474 Neuroblastoma Cot 25-normalized .b 76 to 620 12 to 556       545/603
(90 %)
13 diff
(97.9 %id)
BX357307 Placenta Cot 25-normalized .b 76 to 735 12 to 670       659/671
(98 %)
12 diff
(98.3 %id)
AL531295 brain, fetal liver, Liver, neuroblastoma cells .b 76 to 617 12 to 553       542/558
(97 %)
8 diff
(98.6 %id)
ES312979 beard hair, skin .b 76 to 224 1 to 148       148/148
(100 %)
2 diff
(98.7 %id)
BG107252 lymph, lymphoma, cell line .b 76 to 562 1 to 489       489/489
(100 %)
12 diff
(97.6 %id)
BG107339 lymph, lymphoma, cell line .b 76 to 624 1 to 544       544/662
(82 %)
11 diff
(98.4 %id)
BI767231 pooled lung and spleen .b 76 to 563 1 to 488   AAA   488/646
(75 %)
3 diff
(99.6 %id)
BQ221386 embryonal carcinoma, cell line, testis .b 76 to 687 1 to 616       616/735
(83 %)
8 diff
(99.0 %id)
BQ225832 embryonal carcinoma, cell line, testis .b 76 to 965 1 to 896       896/903
(99 %)
22 diff
(97.6 %id)
BU173636 epithelioid carcinoma, Pancreas .b 76 to 838 1 to 776       776/881
(88 %)
21 diff
(97.7 %id)
BU187153 eye, retinoblastoma .b 76 to 905 1 to 839       839/880
(95 %)
16 diff
(98.2 %id)
BQ424537 melanotic melanoma, skin .b 76 to 737 1 to 661       661/918
(72 %)
25 diff
(97.3 %id)
BU528693 epidermoid carcinoma, cell line, lung .b 76 to 952 33 to 923       891/949
(93 %)
40 diff
(95.8 %id)
TI_57181640   .b 76 to 563 34 to 521   AAA   488/679
(71 %)
12 diff
(98.3 %id)
CN356178 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 77 to 602 1 to 526       526/526
(100 %)
0 diff
(100 %id)
BX325091   .b 77 to 767 1 to 690       690/731
(94 %)
24 diff
(96.8 %id)
BF304013 muscle, rhabdomyosarcoma .b 77 to 630 1 to 554       554/913
(60 %)
7 diff
(99.3 %id)
BG471452 eye, retinoblastoma .b 77 to 633 1 to 574   AAA   572/576
(99 %)
31 diff
(94.7 %id)
BI114127 muscle, rhabdomyosarcoma .b 77 to 643 1 to 568       568/569
(99 %)
5 diff
(99.2 %id)
BM466838 eye, retinoblastoma .b 77 to 577 1 to 503       503/1197
(42 %)
13 diff
(99.0 %id)
BM564663 duodenal adenocarcinoma, cell line, small intestine .b 77 to 846 1 to 776       776/1073
(72 %)
20 diff
(98.2 %id)
BU540998 epithelioid carcinoma cell line, Pancreas .b 77 to 838 1 to 772       772/907
(85 %)
14 diff
(98.5 %id)
CB594924 Blood, promyelocytic leukemia .b 77 to 878 1 to 809       809/892
(90 %)
18 diff
(98.0 %id)
CN356172 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 78 to 623 1 to 547       547/551
(99 %)
7 diff
(98.8 %id)
BM471659 eye, retinoblastoma .b 78 to 1002 1 to 949       949/1093
(86 %)
47 diff
(95.7 %id)
BM468758 embryonal carcinoma, cell line, testis .b 78 to 846 1 to 780       780/1009
(77 %)
38 diff
(96.3 %id)
BU156283 eye, retinoblastoma .b 78 to 878 1 to 815       815/884
(92 %)
21 diff
(97.7 %id)
AA380644   .b 79 to 323 1 to 246       246/246
(100 %)
5 diff
(98.0 %id)
BE271259 Burkitt lymphoma, lymph .b 79 to 637 48 to 603       556/617
(90 %)
12 diff
(98.1 %id)
BQ939795 epidermoid carcinoma, cell line, lung .b 79 to 846 1 to 772       772/987
(78 %)
17 diff
(98.3 %id)
AW963549   .b 80 to 611 1 to 532       532/606
(87 %)
4 diff
(99.4 %id)
BE299211 muscle, rhabdomyosarcoma .b 82 to 621 33 to 577       545/787
(69 %)
14 diff
(98.3 %id)
BM478412 eye, retinoblastoma .b 82 to 557 35 to 510       476/1391
(34 %)
15 diff
(99.0 %id)
CN356180 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 84 to 682 1 to 599       599/599
(100 %)
1 diff
(99.9 %id)
BX361727   .b 84 to 563 1 to 480       480/541
(88 %)
17 diff
(96.9 %id)
AL531142 brain, fetal liver, Liver, neuroblastoma cells .b 84 to 904 1 to 811       811/907
(89 %)
32 diff
(96.5 %id)
BX426962 fetal liver, Liver .b 84 to 1016 1 to 920   fully sequenced,   920/920
(100 %)
32 diff
(96.6 %id)
BX427945 fetal liver, Liver .b 84 to 732 1 to 648       648/653
(99 %)
8 diff
(98.8 %id)
BE300446 muscle, rhabdomyosarcoma .b 84 to 628 32 to 574       543/965
(56 %)
12 diff
(98.8 %id)
BQ057509 lymph, lymphoma, cell line .b 84 to 815 1 to 740       740/1166
(63 %)
12 diff
(99.0 %id)
BQ059071 lymph, lymphoma, cell line .b 84 to 838 1 to 762       762/1090
(69 %)
9 diff
(99.2 %id)
BQ065308 lymph, lymphoma, cell line .b 84 to 974 1 to 906       906/1026
(88 %)
36 diff
(96.5 %id)
BQ065846 lymph, lymphoma, cell line .b 84 to 1020 1 to 953       953/1032
(92 %)
36 diff
(96.6 %id)
BQ229821 embryonal carcinoma, cell line, testis .b 84 to 859 44 to 829       786/976
(80 %)
20 diff
(98.0 %id)
BQ642253 lymph, lymphoma, cell line .b 84 to 866 1 to 792       792/882
(89 %)
17 diff
(98.1 %id)
BQ642477 lymph, lymphoma, cell line .b 84 to 778 1 to 701       701/992
(70 %)
26 diff
(97.4 %id)
BU151387 lymph, lymphoma, cell line .b 84 to 838 1 to 771       771/857
(89 %)
16 diff
(98.2 %id)
BM743687 Ascites, stomach .b 84 to 576 1 to 493       493/493
(100 %)
0 diff
(100 %id)
CN356176 embryonic stem cells, cell lines H1, H7, andH9 .b 85 to 794 1 to 712       712/712
(100 %)
8 diff
(98.9 %id)
BX427607 fetal liver, Liver .b 85 to 735 1 to 651       651/651
(100 %)
17 diff
(97.4 %id)
BM917005 blood, natural killer cells, cell line .b 85 to 818 1 to 753       753/1176
(64 %)
24 diff
(98.0 %id)
BQ054512 lymph, lymphoma, cell line .b 85 to 1002 1 to 940       940/987
(95 %)
37 diff
(96.3 %id)
BQ057728 lymph, lymphoma, cell line .b 85 to 961 1 to 894       894/960
(93 %)
33 diff
(96.6 %id)
BQ642975 lymph, lymphoma, cell line .b 85 to 853 1 to 794       794/881
(90 %)
37 diff
(95.9 %id)
CD558668 White Matter .b 85 to 847 17 to 787       771/971
(79 %)
28 diff
(97.2 %id)
BQ049056 lymph, lymphoma, cell line .b 86 to 847 1 to 769       769/1043
(73 %)
11 diff
(99.0 %id)
BQ217295 embryonal carcinoma, cell line, testis .b 86 to 563 1 to 479       479/910
(52 %)
13 diff
(98.6 %id)
CN356174 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 87 to 468 1 to 382       382/382
(100 %)
0 diff
(100 %id)
BF204647 muscle, rhabdomyosarcoma .b 87 to 631 1 to 546       546/548
(99 %)
5 diff
(99.1 %id)
BE300397 muscle, rhabdomyosarcoma .b 88 to 661 38 to 610   fully sequenced,   573/610
(93 %)
12 diff
(98.1 %id)
BQ949888 large cell carcinoma, lung .b 88 to 937 1 to 856       856/861
(99 %)
15 diff
(98.3 %id)
BX406691 fetal liver, Liver .b 89 to 730 1 to 641       641/641
(100 %)
9 diff
(98.6 %id)
BJ992305 hepatoblastoma .b 89 to 507 1 to 419       419/419
(100 %)
0 diff
(100 %id)
BE019039 muscle, rhabdomyosarcoma .b 89 to 620 1 to 531       531/531
(100 %)
2 diff
(99.7 %id)
BQ057116 lymph, lymphoma, cell line .b 90 to 939 1 to 865       865/927
(93 %)
29 diff
(96.9 %id)
BQ064402 lymph, lymphoma, cell line .b 90 to 1002 1 to 929       929/1009
(92 %)
36 diff
(96.5 %id)
BE254645 eye, retinoblastoma .b 91 to 384 1 to 295       295/296
(99 %)
3 diff
(99.0 %id)
BE278648 choriocarcinoma, placenta .b 91 to 626 1 to 537       537/738
(72 %)
3 diff
(99.6 %id)
BF794131 lymph, lymphoma, cell line .b 91 to 624 1 to 536       536/629
(85 %)
4 diff
(99.4 %id)
BM548922 duodenal adenocarcinoma, cell line, small intestine .b 91 to 804 1 to 737       737/940
(78 %)
43 diff
(95.5 %id)
BE295054 muscle, rhabdomyosarcoma .b 92 to 631 1 to 540       540/542
(99 %)
1 diff
(99.9 %id)
BM799891 eye, retinoblastoma .b 92 to 1041 1 to 954       954/1105
(86 %)
39 diff
(96.5 %id)
BQ224450 epithelioid carcinoma, Pancreas .b 92 to 838 1 to 753       753/858
(87 %)
12 diff
(98.7 %id)
BQ723376 sympathetic trunk .b 92 to 1002 1 to 923       923/923
(100 %)
34 diff
(96.4 %id)
BE250790 eye, retinoblastoma .b 94 to 625 1 to 532       532/535
(99 %)
2 diff
(99.7 %id)
BE294571 muscle, rhabdomyosarcoma .b 94 to 627 1 to 535       535/537
(99 %)
4 diff
(99.3 %id)
BU176016 eye, retinoblastoma .b 94 to 838 1 to 748       748/881
(84 %)
10 diff
(98.9 %id)
BE296883 muscle, rhabdomyosarcoma .b 95 to 629 1 to 534       534/535
(99 %)
4 diff
(99.3 %id)
BE783728 eye, retinoblastoma .b 95 to 623 1 to 530       530/572
(92 %)
7 diff
(98.8 %id)
BE906990 epithelioid carcinoma, Pancreas .b 95 to 618 1 to 524       524/526
(99 %)
1 diff
(99.9 %id)
BE300055 muscle, rhabdomyosarcoma .b 653 to 1378 739 to 7   fully sequenced,   733/739
(99 %)
0 diff
(100 %id)
BE271163 Burkitt lymphoma, lymph .b 776 to 1388 613 to 1       613/614
(99 %)
11 diff
(98.3 %id)
BX448691 fetal liver, Liver .b 870 to 2038 1159 to 1       1159/1194
(97 %)
32 diff
(97.4 %id)
AL571260 placenta, Placenta Cot 25-normalized .b 887 to 2033 1134 to 4       1131/1135
(99 %)
0 diff
(100 %id)
BX405696 fetal liver, Liver .b 919 to 2056 1130 to 1       1130/1150
(98 %)
30 diff
(97.4 %id)
BE207819 muscle, rhabdomyosarcoma .b 962 to 1441 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AL579749 T cells from T cell leukemia .b 965 to 2001 1020 to 1       1020/1041
(97 %)
54 diff
(94.9 %id)
AL531294 brain, fetal liver, Liver, neuroblastoma cells .b 965 to 2060 1086 to 1       1086/1109
(97 %)
22 diff
(98.1 %id)
BX405500 fetal liver, Liver .b 976 to 2051 1067 to 1   fully sequenced,   1067/1067
(100 %)
6 diff
(99.5 %id)
BX426961 fetal liver, Liver .b 986 to 2035 1048 to 1   fully sequenced,   1048/1048
(100 %)
3 diff
(99.8 %id)
AL563963 brain, fetal liver, Liver, neuroblastoma cells .b 991 to 2028 1040 to 11       1030/1044
(98 %)
0 diff
(100 %id)
BX388028   .b 1011 to 2052 1042 to 1   fully sequenced,   1042/1042
(100 %)
8 diff
(99.3 %id)
BX427606 fetal liver, Liver .b 1050 to 2036 987 to 6       982/987
(99 %)
0 diff
(100 %id)
BX406690 fetal liver, Liver .b 1055 to 2027 971 to 2       970/981
(98 %)
0 diff
(100 %id)
BX427944 fetal liver, Liver .b 1067 to 2041 969 to 1       969/969
(100 %)
32 diff
(96.7 %id)
AL580017 T cells from T cell leukemia .b 1098 to 2008 900 to 1       900/928
(96 %)
18 diff
(98.1 %id)
BX426714 fetal liver, Liver .b 1121 to 2041 925 to 1       925/957
(96 %)
29 diff
(97.0 %id)
BX448038 fetal liver, Liver .b 1125 to 2045 921 to 1       921/921
(100 %)
10 diff
(99.0 %id)
BX325090   .b 1131 to 2021 894 to 1       894/894
(100 %)
11 diff
(98.8 %id)
BX392578 Placenta Cot 25-normalized .b 1433 to 2067 630 to 1       630/630
(100 %)
11 diff
(98.3 %id)
DB323588   .b 1524 to 2068 546 to 1       546/546
(100 %)
1 diff
(99.9 %id)
DA251296 caudate nucleus .c 1 to 544 2 to 545   tiling clone, capped   544/544
(100 %)
0 diff
(100 %id)
DA684664   .c 1 to 542 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
NM_012068.4   .c 15 to 2278 1 to 2264 exact RefSeq,   2264/2268
(99 %)
5 diff
(99.8 %id)
DA328959 hippocampus .c 16 to 507 2 to 493   capped   492/492
(100 %)
2 diff
(99.6 %id)
BG481450 choriocarcinoma, placenta .c 40 to 820 1 to 783       783/785
(99 %)
14 diff
(98.3 %id)
BG480673 choriocarcinoma, placenta .c 40 to 692 1 to 662       662/720
(91 %)
19 diff
(97.4 %id)
AK290592   .c 61 to 1636 1 to 1576 A14T     1576/1576
(100 %)
3 diff
(99.9 %id)
BE732759 choriocarcinoma, placenta .c 61 to 693 1 to 633       633/633
(100 %)
2 diff
(99.7 %id)
BE732543 choriocarcinoma, placenta .c 61 to 675 1 to 615       615/615
(100 %)
0 diff
(100 %id)
DA554833   .c 62 to 617 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BE897268 melanotic melanoma, skin .c 105 to 820 1 to 714   AAA   714/912
(78 %)
15 diff
(98.4 %id)
BG323270 Kidney, renal cell adenocarcinoma .c 279 to 828 1 to 546       546/855
(63 %)
28 diff
(96.8 %id)
BI261865 lymph, lymphoma, cell line .c 287 to 826 1 to 536       536/543
(98 %)
13 diff
(97.7 %id)
BF683409 leiomyosarcoma cell line, uterus .c 289 to 833 1 to 547       547/887
(61 %)
18 diff
(98.0 %id)
BG827499 muscle, rhabdomyosarcoma .c 289 to 722 1 to 441       441/569
(77 %)
13 diff
(97.8 %id)
BM806978 lymph, lymphoma, cell line .c 291 to 931 12 to 661       650/1185
(54 %)
30 diff
(97.5 %id)
BF982575 duodenal adenocarcinoma, cell line, small intestine .c 295 to 840 1 to 548   AAA   548/629
(87 %)
10 diff
(98.5 %id)
BF797990 lymph, lymphoma, cell line .c 296 to 761 1 to 469       469/1003
(46 %)
5 diff
(99.6 %id)
BE782507 eye, retinoblastoma .c 299 to 840 1 to 541       541/889
(60 %)
12 diff
(98.7 %id)
BE891304 melanotic melanoma, skin .c 299 to 822 1 to 523       523/525
(99 %)
4 diff
(99.3 %id)
BE781269 eye, retinoblastoma .c 300 to 834 1 to 531       531/899
(59 %)
9 diff
(99.0 %id)
BE909074 epithelioid carcinoma, Pancreas .c 301 to 814 1 to 516       516/516
(100 %)
11 diff
(97.9 %id)
BX346235   .c 302 to 877 1 to 574       574/578
(99 %)
14 diff
(97.6 %id)
BF205348 muscle, rhabdomyosarcoma .c 303 to 826 1 to 523       523/575
(90 %)
5 diff
(99.2 %id)
BF205583 muscle, rhabdomyosarcoma .c 303 to 827 1 to 525       525/560
(93 %)
7 diff
(98.8 %id)
BF568690 epithelioid carcinoma cell line, Pancreas .c 305 to 830 21 to 548       528/565
(93 %)
15 diff
(97.4 %id)
AL531107 brain, fetal liver, Liver, neuroblastoma cells .c 307 to 830 1 to 524       524/649
(80 %)
4 diff
(99.4 %id)
BE298630 muscle, rhabdomyosarcoma .c 310 to 845 1 to 537       537/538
(99 %)
5 diff
(99.1 %id)
BF568254 epithelioid carcinoma cell line, Pancreas .c 317 to 838 37 to 559       523/586
(89 %)
9 diff
(98.5 %id)
BI194798 epithelioid carcinoma cell line, Pancreas .c 318 to 837 84 to 615       532/615
(86 %)
20 diff
(96.8 %id)
BQ061792 lymph, lymphoma, cell line .c 319 to 1178 1 to 882       882/969
(91 %)
34 diff
(96.5 %id)
BQ061794 lymph, lymphoma, cell line .c 319 to 1222 1 to 930       930/1041
(89 %)
38 diff
(96.4 %id)
BJ995703 hepatoblastoma .c 327 to 825 1 to 499       499/506
(98 %)
2 diff
(99.7 %id)
BI160864 epithelioid carcinoma cell line, Pancreas .c 328 to 825 56 to 553       498/553
(90 %)
9 diff
(98.4 %id)
BG829302 muscle, rhabdomyosarcoma .c 330 to 753 48 to 453       384/453
(84 %)
24 diff
(94.8 %id)
BM462249 eye, retinoblastoma .c 364 to 1353 1 to 996   tiling clone,   996/1073
(92 %)
42 diff
(96.1 %id)
BF973115 leiomyosarcoma cell line, uterus .c 406 to 831 1 to 425       425/642
(66 %)
7 diff
(99.0 %id)
BG481234 choriocarcinoma, placenta .c 414 to 928 1 to 519       519/529
(98 %)
17 diff
(96.8 %id)
BU184829 adenocarcinoma, Pancreas .c 414 to 1224 1 to 813       813/920
(88 %)
23 diff
(97.5 %id)
BG827800 muscle, rhabdomyosarcoma .c 422 to 832 1 to 415   AAA   415/518
(80 %)
11 diff
(97.9 %id)
DA902960   .c 478 to 946 2 to 470   capped   469/469
(100 %)
1 diff
(99.8 %id)
BF844861 head_neck .c 490 to 665 176 to 3     Submitted on the opposite strand 174/176
(98 %)
0 diff
(100 %id)
BX448909 fetal liver, Liver .c 501 to 941 1 to 439       413/439
(94 %)
19 diff
(95.7 %id)
AF305687   .c 532 to 1636 1 to 1105 exact     1105/1105
(100 %)
1 diff
(100.0 %id)
BE255770 eye, retinoblastoma .c 549 to 834 1 to 289       289/446
(64 %)
5 diff
(98.9 %id)
BF685935 leiomyosarcoma cell line, uterus .c 622 to 843 1 to 221       221/242
(91 %)
7 diff
(97.2 %id)
T71531 Liver .c 771 to 1030 1 to 261       261/285
(91 %)
10 diff
(96.5 %id)
T67794 Liver .c 772 to 1129 1 to 356       356/356
(100 %)
6 diff
(98.4 %id)
BX452347 fetal liver, Liver .c 790 to 1719 1 to 919       919/924
(99 %)
44 diff
(95.3 %id)
AA344893 gall bladder .c 791 to 941 1 to 151       151/151
(100 %)
1 diff
(99.4 %id)
BQ066477 lymph, lymphoma, cell line .c 793 to 1655 1 to 869       869/999
(86 %)
24 diff
(97.6 %id)
BF570289 Kidney, renal carcinoma (ascites) .c 854 to 1588 749 to 1       749/996
(75 %)
22 diff
(97.8 %id)
BE313521 brain, neuroblastoma .c 888 to 1455 50 to 619       570/657
(86 %)
24 diff
(96.4 %id)
BQ672247 epidermoid carcinoma, cell line, salivary gland .c 894 to 1708 1 to 821       821/886
(92 %)
20 diff
(97.8 %id)
T67671 liver and spleen .c 912 to 1275 1 to 369       369/425
(86 %)
15 diff
(96.5 %id)
T85072 liver and spleen .c 913 to 1278 1 to 379       379/438
(86 %)
26 diff
(94.1 %id)
BM724181 eye, fetal eye .c 916 to 1607 1 to 690   fully sequenced,   690/690
(100 %)
3 diff
(99.6 %id)
AA191110   .c 930 to 1292 1 to 354   fully sequenced,   354/354
(100 %)
14 diff
(96.1 %id)
H46645 breast .c 941 to 1315 1 to 389   fully sequenced,   389/389
(100 %)
15 diff
(96.2 %id)
BF569287 epithelioid carcinoma cell line, Pancreas .c 976 to 1584 624 to 1       745/1227
(60 %)
54 diff
(95.6 %id)
BF568997 epithelioid carcinoma cell line, Pancreas .c 981 to 1563 612 to 20       593/615
(96 %)
0 diff
(100 %id)
BI262387 lymph, lymphoma, cell line .c 982 to 1581 607 to 5       603/607
(99 %)
0 diff
(100 %id)
BQ050809 leiomyosarcoma, uterus .c 989 to 1842 1 to 859       859/1043
(82 %)
11 diff
(99.0 %id)
BU188628 melanotic melanoma, skin .c 990 to 1636 690 to 41   AAA Submitted on the opposite strand 650/817
(79 %)
13 diff
(98.5 %id)
BE300269 muscle, rhabdomyosarcoma .c 991 to 1630 656 to 13       644/971
(66 %)
0 diff
(100 %id)
CF146207 CNCAP(3)T-225 cell line, Prostate .c 1000 to 1765 1 to 764       764/764
(100 %)
7 diff
(99.1 %id)
CF146231 CNCAP(3)T-225 cell line, Prostate .c 1000 to 1713 1 to 713       713/713
(100 %)
14 diff
(98.1 %id)
TI_154178650   .c 1006 to 1858 75 to 926       852/928
(91 %)
47 diff
(95.0 %id)
TI_154178601   .c 1007 to 1840 67 to 897       831/831
(100 %)
10 diff
(98.8 %id)
TI_154178633   .c 1007 to 1858 73 to 920       848/852
(99 %)
18 diff
(97.9 %id)
BI160906 epithelioid carcinoma cell line, Pancreas .c 1011 to 1642 1 to 651       651/747
(87 %)
35 diff
(95.4 %id)
BG474147 eye, retinoblastoma .c 1013 to 1496 1 to 478       478/478
(100 %)
10 diff
(98.0 %id)
BG397513 B-cells, primary B-cells from tonsils (cell line) .c 1021 to 1755 1 to 731       731/964
(75 %)
18 diff
(98.2 %id)
BQ643505 lymph, lymphoma, cell line .c 1022 to 1842 1 to 827       827/854
(96 %)
10 diff
(98.9 %id)
BM479702 eye, retinoblastoma .c 1029 to 1915 1 to 891   tiling clone,   891/1080
(82 %)
9 diff
(99.2 %id)
CA432396 cell lines, Chondrosarcoma .c 1030 to 1636 625 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 607/607
(100 %)
0 diff
(100 %id)
BQ425181 eye, retinoblastoma .c 1054 to 1636 12 to 594   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 583/594
(98 %)
5 diff
(99.2 %id)
BX344412   .c 1057 to 2240 1179 to 1       1179/1184
(99 %)
20 diff
(98.4 %id)
AA513805 breast .c 1059 to 1636 579 to 1     Submitted on the opposite strand 579/579
(100 %)
6 diff
(99.0 %id)
AF101388   .c 1064 to 1636 3 to 575   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 573/575
(99 %)
6 diff
(99.0 %id)
BU626285 Bone, Subchondral Bone .c 1069 to 1636 585 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 567/567
(100 %)
4 diff
(99.3 %id)
AA512936 breast .c 1110 to 1635 526 to 1       526/526
(100 %)
0 diff
(100 %id)
BE905882 epithelioid carcinoma, Pancreas .c 1126 to 1631 1 to 504       504/504
(100 %)
5 diff
(99.1 %id)
D31104   .c 1131 to 1431 1 to 300       300/300
(100 %)
1 diff
(99.7 %id)
T67718 Liver .c 1132 to 1635 522 to 1       522/526
(99 %)
30 diff
(94.3 %id)
T71368 Liver .c 1138 to 1606 479 to 1       479/479
(100 %)
18 diff
(96.3 %id)
AI870651 anaplastic oligodendroglioma, brain .c 1144 to 1636 493 to 1       493/493
(100 %)
0 diff
(100 %id)
BI254303 cervical carcinoma cell line, cervix .c 1162 to 1641 1 to 479       479/832
(57 %)
6 diff
(99.3 %id)
BM665601 eye, human retina .c 1162 to 1636 493 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 475/475
(100 %)
1 diff
(99.8 %id)
AW629156 pooled .c 1166 to 1636 471 to 1       471/471
(100 %)
1 diff
(99.8 %id)
BU963281 mixed (pool of 40 RNAs) .c 1199 to 1635 1 to 437       437/438
(99 %)
4 diff
(99.1 %id)
AA292328.
matches multiple genes
ovarian tumor, ovary .c 1206 to 1635 431 to 1     also hits gene LANCL3 431/431
(100 %)
3 diff
(99.4 %id)
AA815137 germinal center B cell .c 1206 to 1634 430 to 2       429/430
(99 %)
0 diff
(100 %id)
AA994765 breast .c 1206 to 1636 431 to 1       431/431
(100 %)
5 diff
(98.9 %id)
AL579718 T cells from T cell leukemia .c 1215 to 2114 996 to 103       894/1024
(87 %)
0 diff
(100 %id)
BU539630 adenocarcinoma, cell line, breast .c 1220 to 1809 1 to 592       592/985
(60 %)
7 diff
(99.3 %id)
BU539728 adenocarcinoma, cell line, breast .c 1221 to 1729 1 to 510       510/1139
(44 %)
12 diff
(99.0 %id)
N59773 liver and spleen .c 1222 to 1638 419 to 1       419/430
(97 %)
10 diff
(97.7 %id)
AI000315 pooled germ cell tumors .c 1227 to 1413 187 to 1       187/187
(100 %)
14 diff
(92.6 %id)
BF793311 adrenal cortex carcinoma, cell line, adrenal gland .c 1232 to 1648 1 to 415       415/419
(99 %)
5 diff
(98.9 %id)
BX346234   .c 1236 to 2246 1009 to 1       1009/1012
(99 %)
14 diff
(98.7 %id)
BE908491 epithelioid carcinoma, Pancreas .c 1252 to 1874 1 to 635       635/852
(74 %)
37 diff
(95.7 %id)
AA161164 Pancreas .c 1256 to 1636 382 to 1       382/438
(87 %)
10 diff
(97.8 %id)
CB164126 Liver .c 1257 to 1746 1 to 490       490/490
(100 %)
0 diff
(100 %id)
AL531375 brain, fetal liver, Liver, neuroblastoma cells .c 1259 to 2218 952 to 1       952/1015
(93 %)
17 diff
(98.4 %id)
AA191099   .c 1262 to 1646 384 to 1   fully sequenced,   384/384
(100 %)
6 diff
(98.5 %id)
BG497003 lung, mucoepidermoid carcinoma .c 1265 to 1928 1 to 679       679/679
(100 %)
36 diff
(94.7 %id)
W56638 heart .c 1268 to 1636 11 to 376   fully sequenced,   366/376
(97 %)
7 diff
(98.2 %id)
H46624 breast .c 1285 to 1595 316 to 1   fully sequenced,   316/316
(100 %)
9 diff
(97.2 %id)
T64935 liver and spleen .c 1288 to 1636 350 to 1       350/350
(100 %)
12 diff
(96.6 %id)
R06908 liver and spleen .c 1301 to 1626 330 to 1       330/332
(99 %)
17 diff
(94.9 %id)
BQ673832 epidermoid carcinoma, cell line, salivary gland .c 1305 to 2163 1 to 874       874/900
(97 %)
23 diff
(97.5 %id)
CN356170 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 1317 to 2052 1 to 736       736/736
(100 %)
0 diff
(100 %id)
BF748144 breast_normal .c 1330 to 1626 292 to 1     Submitted on the opposite strand 292/297
(98 %)
14 diff
(95.3 %id)
BG978355 colon_ins .c 1330 to 1636 1 to 308   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 308/308
(100 %)
8 diff
(97.5 %id)
T85073 liver and spleen .c 1347 to 1635 289 to 2       288/289
(99 %)
0 diff
(100 %id)
DN916449   .c 1348 to 1922 1 to 574       574/574
(100 %)
7 diff
(98.8 %id)
BM450550 eye, retinoblastoma .c 1370 to 1636 1 to 267   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 267/267
(100 %)
0 diff
(100 %id)
N58999 multiple sclerosis lesions .c 1371 to 1636 1 to 267   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 267/267
(100 %)
3 diff
(98.9 %id)
AL563946 brain, fetal liver, Liver, neuroblastoma cells .c 1376 to 2232 861 to 1       861/1030
(83 %)
10 diff
(99.1 %id)
BP431466   .c 1421 to 1777 1 to 358       358/358
(100 %)
5 diff
(98.7 %id)
W56601 heart .c 1427 to 1636 209 to 1   fully sequenced,   209/209
(100 %)
2 diff
(99.1 %id)
BX448908 fetal liver, Liver .c 1438 to 2238 801 to 1       801/808
(99 %)
17 diff
(97.9 %id)
AW888902 nervous_tumor .c 1439 to 1713 11 to 280       270/287
(94 %)
9 diff
(96.9 %id)
AW390226 stomach .c 1453 to 2007 557 to 3       555/563
(98 %)
0 diff
(100 %id)
BF089401 head_neck .c 1466 to 1713 1 to 246       246/246
(100 %)
7 diff
(97.2 %id)
AA465295 germinal center B cell .c 1475 to 1819 6 to 350   fully sequenced,   345/350
(98 %)
6 diff
(98.3 %id)
H27386 breast .c 1532 to 1856 1 to 328       328/335
(97 %)
5 diff
(98.6 %id)
AW856281 colon .c 1564 to 1788 1 to 224       224/236
(94 %)
12 diff
(95.0 %id)
R99387 liver and spleen .c 1576 to 1829 1 to 260   fully sequenced,   260/260
(100 %)
1 diff
(99.7 %id)
BM680343 eye, fetal eye .c 1577 to 2168 594 to 1   fully sequenced,   594/594
(100 %)
8 diff
(98.7 %id)
AV700911 hepatocellular carcinoma .c 1590 to 2254 664 to 1       664/665
(99 %)
13 diff
(98.1 %id)
CB157034 Liver .c 1591 to 2081 1 to 492       492/492
(100 %)
6 diff
(98.8 %id)
CB164612 Liver .c 1591 to 2081 1 to 491       491/491
(100 %)
5 diff
(99.0 %id)
BI870273 adenocarcinoma, cell line, Liver .c 1593 to 2266 1 to 677       677/780
(86 %)
10 diff
(98.8 %id)
TI_57229266   .c 1593 to 2266 87 to 763       677/780
(86 %)
10 diff
(98.8 %id)
BM747655 stomach .c 1594 to 1920 1 to 329       329/329
(100 %)
9 diff
(97.3 %id)
N44222 multiple sclerosis lesions .c 1598 to 1787 1 to 190   fully sequenced,   190/190
(100 %)
1 diff
(99.5 %id)
BX100902 liver and spleen .c 1619 to 2273 1 to 655   tiling clone, AAA   655/655
(100 %)
0 diff
(100 %id)
R07946 liver and spleen .c 1619 to 1915 1 to 302       302/431
(70 %)
9 diff
(98.0 %id)
R08306 liver and spleen .c 1619 to 1816 1 to 200       200/206
(97 %)
3 diff
(98.6 %id)
H53559 liver and spleen .c 1619 to 1988 1 to 376   fully sequenced,   376/376
(100 %)
6 diff
(98.5 %id)
BM469394 lymph, lymphoma, cell line .c 1642 to 2268 800 to 167   AAA Submitted on the opposite strand 634/1165
(54 %)
0 diff
(100 %id)
AA714781 germinal center B cell .c 1649 to 2105 457 to 1       457/457
(100 %)
2 diff
(99.6 %id)
BE709034 head_neck .c 1650 to 2034 392 to 10       383/406
(94 %)
0 diff
(100 %id)
AW971750   .c 1651 to 2154 504 to 1     Submitted on the opposite strand 504/515
(97 %)
2 diff
(99.7 %id)
T73635 Liver .c 1656 to 2057 1 to 417       417/419
(99 %)
17 diff
(96.0 %id)
AA345127 gall bladder .c 1661 to 1878 1 to 218       218/218
(100 %)
0 diff
(100 %id)
BE064024 breast .c 1662 to 2044 1 to 382       382/384
(99 %)
6 diff
(98.5 %id)
AW393028 stomach .c 1672 to 1911 8 to 240       233/240
(97 %)
6 diff
(97.5 %id)
CA429625 Cell Line, Chondrosarcoma .c 1672 to 2272 619 to 19   AAA   601/601
(100 %)
0 diff
(100 %id)
AW371587 breast .c 1673 to 2044 268 to 638       371/640
(57 %)
5 diff
(99.3 %id)
AW381810 head_neck .c 1673 to 2037 372 to 9       364/386
(94 %)
0 diff
(100 %id)
AW392058 stomach .c 1673 to 2044 13 to 383       371/386
(96 %)
6 diff
(98.5 %id)
AW601282 breast .c 1673 to 2030 364 to 7       358/378
(94 %)
0 diff
(100 %id)
AW601284 breast .c 1673 to 2019 348 to 4       345/362
(95 %)
0 diff
(100 %id)
AW601286 breast .c 1673 to 2024 353 to 2       352/367
(95 %)
0 diff
(100 %id)
AW601287 breast .c 1673 to 2030 363 to 6       358/377
(94 %)
0 diff
(100 %id)
AW601288 breast .c 1673 to 2005 333 to 1       333/347
(95 %)
0 diff
(100 %id)
BE063943 breast .c 1673 to 2020 347 to 2     Submitted on the opposite strand 346/361
(95 %)
0 diff
(100 %id)
BE063945 breast .c 1673 to 2007 339 to 5     Submitted on the opposite strand 335/353
(94 %)
0 diff
(100 %id)
BE063947 breast .c 1673 to 2009 339 to 4     Submitted on the opposite strand 336/353
(95 %)
0 diff
(100 %id)
BE063948 breast .c 1673 to 2034 360 to 2     Submitted on the opposite strand 359/374
(95 %)
7 diff
(98.2 %id)
BE063949 breast .c 1673 to 2020 350 to 6     Submitted on the opposite strand 345/364
(94 %)
0 diff
(100 %id)
BE063950 breast .c 1673 to 2028 355 to 1     Submitted on the opposite strand 355/369
(96 %)
3 diff
(99.2 %id)
BE063951 breast .c 1673 to 2048 390 to 15     Submitted on the opposite strand 376/404
(93 %)
0 diff
(100 %id)
BE063954 breast .c 1673 to 2021 347 to 1     Submitted on the opposite strand 347/361
(96 %)
3 diff
(99.2 %id)
BE064022 breast .c 1673 to 2037 372 to 9     Submitted on the opposite strand 364/386
(94 %)
0 diff
(100 %id)
BF330716 breast .c 1673 to 2032 375 to 19       357/389
(91 %)
0 diff
(100 %id)
DN916448   .c 1675 to 2270 596 to 1       596/596
(100 %)
5 diff
(99.2 %id)
BF109248 pooled .c 1676 to 2271 596 to 1       596/596
(100 %)
6 diff
(99.0 %id)
AW393041 stomach .c 1678 to 1911 14 to 241       228/241
(94 %)
6 diff
(97.6 %id)
AW393063 stomach .c 1679 to 1909 247 to 22       226/247
(91 %)
0 diff
(100 %id)
AW991637 breast_normal .c 1679 to 1930 252 to 7     Submitted on the opposite strand 246/252
(97 %)
0 diff
(100 %id)
BE937521 stomach .c 1679 to 1917 246 to 8       239/246
(97 %)
0 diff
(100 %id)
AI658680 Prostate .c 1681 to 2273 594 to 2       593/594
(99 %)
0 diff
(100 %id)
T54592 fetal spleen, Spleen .c 1682 to 1915 1 to 243       243/281
(86 %)
12 diff
(95.8 %id)
BE395604 endometrium, adenocarcinoma cell line, uterus .c 1701 to 2273 1 to 577       577/658
(87 %)
15 diff
(97.8 %id)
BJ995704 hepatoblastoma .c 1711 to 2250 540 to 1       540/540
(100 %)
17 diff
(96.9 %id)
BM704384 eye, RPE and Choroid .c 1719 to 2256 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BG236154 blood, lymphocyte .c 1726 to 2272 550 to 4       547/550
(99 %)
0 diff
(100 %id)
BI260738 cervical carcinoma cell line, cervix .c 1733 to 2272 23 to 562   AAA   540/562
(96 %)
6 diff
(99.0 %id)
BF688051 brain, glioblastoma .c 1738 to 2272 1 to 531   AAA   531/531
(100 %)
19 diff
(96.5 %id)
H65944 liver and spleen .c 1751 to 2133 386 to 1       386/390
(98 %)
4 diff
(99.0 %id)
N34330 multiple sclerosis lesions .c 1757 to 2152 400 to 1   fully sequenced,   400/400
(100 %)
10 diff
(97.5 %id)
AI769302 pooled .c 1759 to 2271 525 to 13   AAA   513/513
(100 %)
2 diff
(99.7 %id)
AW675052 cervix .c 1760 to 2011 1 to 252   fully sequenced,   252/252
(100 %)
0 diff
(100 %id)
BE467506 carcinoid, lung .c 1761 to 2273 515 to 3       513/515
(99 %)
0 diff
(100 %id)
BG389661 embryonal carcinoma, cell line, testis .c 1769 to 2273 9 to 513   AAA   505/513
(98 %)
6 diff
(98.9 %id)
BG389819 embryonal carcinoma, cell line, testis .c 1769 to 2273 8 to 511       504/840
(60 %)
11 diff
(98.7 %id)
TI_159704585   .c 1769 to 2272 609 to 106   AAA   504/1032
(48 %)
2 diff
(99.9 %id)
BG114711 duodenal adenocarcinoma, cell line, small intestine .c 1770 to 2272 1 to 512   AAA   512/512
(100 %)
17 diff
(96.7 %id)
BU754462 placenta .c 1770 to 2273 522 to 19   AAA   504/504
(100 %)
6 diff
(98.9 %id)
AW803131 uterus .c 1772 to 2038 274 to 8       267/285
(93 %)
0 diff
(100 %id)
AW872383 carcinoid, lung .c 1785 to 2269 487 to 3       485/487
(99 %)
0 diff
(100 %id)
AI871397 anaplastic oligodendroglioma, brain .c 1788 to 2270 494 to 12   AAA   483/483
(100 %)
4 diff
(99.2 %id)
AA496253 germinal center B cell .c 1789 to 2105 317 to 1   fully sequenced,   317/317
(100 %)
1 diff
(99.7 %id)
N25046 nose, olfactory epithelium .c 1791 to 2272 490 to 3       488/491
(99 %)
0 diff
(100 %id)
BE909066 epithelioid carcinoma, Pancreas .c 1792 to 2269 1 to 479       479/484
(98 %)
2 diff
(99.6 %id)
BE909353 epithelioid carcinoma, Pancreas .c 1794 to 2273 1 to 478       478/478
(100 %)
9 diff
(98.2 %id)
R99298 liver and spleen .c 1799 to 2148 355 to 1   fully sequenced,   355/355
(100 %)
2 diff
(99.5 %id)
BQ219100 epithelioid carcinoma, Pancreas .c 1824 to 2273 1 to 450       450/953
(47 %)
0 diff
(100 %id)
AA179101 muscle, skeletal muscle .c 1834 to 2250 1 to 419       419/419
(100 %)
2 diff
(99.6 %id)
AA421049   .c 1834 to 2273 450 to 11   AAA   440/440
(100 %)
0 diff
(100 %id)
CB160225 Liver .c 1837 to 2272 475 to 40   AAA Submitted on the opposite strand 436/436
(100 %)
0 diff
(100 %id)
AI380622 B-cell, chronic lymphotic leukemia .c 1840 to 2273 451 to 18   AAA   434/435
(99 %)
1 diff
(99.8 %id)
AI658606 Prostate .c 1840 to 2272 448 to 15   AAA   434/435
(99 %)
6 diff
(98.7 %id)
AW005082 anaplastic oligodendroglioma, brain .c 1840 to 2272 446 to 14   AAA   433/434
(99 %)
4 diff
(99.1 %id)
AI499815 anaplastic oligodendroglioma, brain .c 1841 to 2273 446 to 14   AAA   433/433
(100 %)
0 diff
(100 %id)
BM466687 eye, retinoblastoma .c 1842 to 2272 56 to 485   AAA   430/485
(88 %)
6 diff
(98.8 %id)
AI087208 senescent fibroblast .c 1844 to 2272 434 to 6       429/434
(98 %)
0 diff
(100 %id)
AI434572 lymph node, lymphoma, follicular mixed small and largecell .c 1844 to 2273 436 to 7       430/436
(98 %)
0 diff
(100 %id)
R71935 breast .c 1849 to 2256 440 to 20       421/442
(95 %)
0 diff
(100 %id)
AA628172   .c 1850 to 2273 424 to 1       424/424
(100 %)
3 diff
(99.3 %id)
AA747921 germinal center B cell .c 1853 to 2155 313 to 11   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 303/303
(100 %)
1 diff
(99.7 %id)
AA987954 carcinoid, lung .c 1858 to 2273 418 to 3       416/418
(99 %)
0 diff
(100 %id)
BE063944 breast .c 1867 to 2044 1 to 176       176/178
(98 %)
8 diff
(95.6 %id)
BM150664 leukopheresis .c 1874 to 2273 416 to 17       400/421
(95 %)
0 diff
(100 %id)
AI720657 colon .c 1881 to 2272 395 to 4       392/395
(99 %)
0 diff
(100 %id)
AI796847 carcinoid, lung .c 1889 to 2229 345 to 5       341/345
(98 %)
0 diff
(100 %id)
AI281663 esophagus, squamous cell carcinoma .c 1895 to 2272 378 to 1       378/378
(100 %)
1 diff
(99.8 %id)
AI720641 colon .c 1897 to 2262 376 to 11       366/376
(97 %)
0 diff
(100 %id)
AW594699 pooled germ cell tumors .c 1900 to 2273 388 to 11   AAA   378/378
(100 %)
4 diff
(99.0 %id)
AI142566 brain, glioblastoma (pooled) .c 1905 to 2272 372 to 5       368/372
(98 %)
0 diff
(100 %id)
AW137984   .c 1905 to 2273 386 to 18   AAA   369/369
(100 %)
1 diff
(99.8 %id)
BM476056 eye, retinoblastoma .c 1916 to 2272 1 to 357   AAA   357/357
(100 %)
0 diff
(100 %id)
AW132070 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1937 to 2272 354 to 17   AAA   338/338
(100 %)
4 diff
(98.9 %id)
AA777352 liver and spleen .c 1940 to 2272 333 to 1       333/333
(100 %)
1 diff
(99.7 %id)
AI245309 Kidney .c 1947 to 2273 354 to 28   AAA   327/327
(100 %)
15 diff
(95.5 %id)
R08307 liver and spleen .c 1948 to 2269 343 to 9       335/344
(97 %)
0 diff
(100 %id)
H53560 liver and spleen .c 1958 to 2249 296 to 1   fully sequenced,   296/296
(100 %)
3 diff
(99.0 %id)
AW674321 cervix .c 1981 to 2273 293 to 1   fully sequenced,   293/293
(100 %)
1 diff
(99.7 %id)
BM682259 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1984 to 2273 308 to 19   AAA   290/296
(97 %)
0 diff
(100 %id)
BM932122 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1987 to 2273 1 to 287   AAA   287/287
(100 %)
0 diff
(100 %id)
AA969757 2 pooled tumors (clear cell type), Kidney .c 1999 to 2273 281 to 7       275/281
(97 %)
0 diff
(100 %id)
BP384565 pancreatic islet .c 2034 to 2262 1 to 229     Submitted on the opposite strand 229/229
(100 %)
1 diff
(99.6 %id)
EC500139 Prostate .c 2060 to 2158 1 to 99       99/99
(100 %)
4 diff
(96.0 %id)
AI024020 liver and spleen .c 2063 to 2272 212 to 3       210/212
(99 %)
0 diff
(100 %id)
EC558735 Prostate .c 2068 to 2158 1 to 91       91/91
(100 %)
1 diff
(99.0 %id)
BM021450 Islets of Langerhans, Pancreas .c 2084 to 2273 1 to 190       190/204
(93 %)
1 diff
(99.6 %id)
BM023461 Islets of Langerhans, Pancreas .c 2084 to 2273 1 to 190       190/216
(87 %)
1 diff
(99.6 %id)
CB105164 Liver .c 2130 to 2272 1 to 143       143/148
(96 %)
1 diff
(99.4 %id)
R62943 placenta .d -8 to 353 1 to 363       363/365
(99 %)
17 diff
(95.4 %id)
AL705922 human skeletal muscle .d 1 to 540 2 to 540 exact tiling clone,   540/540
(100 %)
4 diff
(99.3 %id)
R62518 placenta .d 1 to 279 8 to 289       282/290
(97 %)
10 diff
(96.6 %id)
CF147011 CNCAP(3)T-225 cell line, Prostate .d 9 to 697 1 to 687       687/687
(100 %)
8 diff
(98.9 %id)
CF147017 CNCAP(3)T-225 cell line, Prostate .d 9 to 629 1 to 619       619/619
(100 %)
8 diff
(98.8 %id)
TI_154179563   .d 16 to 823 73 to 874       802/802
(100 %)
13 diff
(98.4 %id)
TI_154179569   .d 16 to 884 79 to 938       860/860
(100 %)
20 diff
(97.7 %id)
H50590 liver and spleen .d 30 to 253 1 to 229   fully sequenced,   229/229
(100 %)
1 diff
(99.6 %id)
H48684 liver and spleen .d 33 to 230 1 to 198   fully sequenced,   198/198
(100 %)
2 diff
(99.0 %id)
AA946877 2 pooled tumors (clear cell type), Kidney .d 136 to 595 455 to 3       453/477
(94 %)
13 diff
(97.3 %id)
AI087063 B-cell, chronic lymphotic leukemia .d 149 to 593 469 to 25   AAA   445/445
(100 %)
1 diff
(99.8 %id)
H48515 liver and spleen .d 169 to 583 422 to 1   fully sequenced,   422/422
(100 %)
14 diff
(96.7 %id)
T81426 liver and spleen .d 201 to 595 403 to 7       397/441
(90 %)
0 diff
(100 %id)
H50591 liver and spleen .d 223 to 584 365 to 1   fully sequenced,   365/365
(100 %)
11 diff
(97.0 %id)
H54406 liver and spleen .d 248 to 572 330 to 1       330/367
(89 %)
11 diff
(97.1 %id)
N71048 liver and spleen .d 299 to 593 298 to 1       298/298
(100 %)
9 diff
(97.0 %id)
AA872225 2 pooled tumors (clear cell type), Kidney .d 315 to 595 282 to 2       281/282
(99 %)
0 diff
(100 %id)
R62519 placenta .d 320 to 591 275 to 2       274/275
(99 %)
0 diff
(100 %id)
T90841 liver and spleen .d 327 to 587 266 to 8       259/268
(96 %)
0 diff
(100 %id)
R62944 placenta .d 375 to 590 217 to 2       216/217
(99 %)
0 diff
(100 %id)
TI_227715539   .d 410 to 1287 957 to 89   AAA   869/984
(88 %)
18 diff
(98.2 %id)
AW977641   .d 427 to 954 528 to 1   tiling clone, Submitted on the opposite strand 528/528
(100 %)
0 diff
(100 %id)
BG056427 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .d 510 to 955 447 to 1       447/447
(100 %)
2 diff
(99.6 %id)
AA810930 germinal center B cell .d 555 to 902 349 to 2       348/349
(99 %)
0 diff
(100 %id)
R89125 liver and spleen .d 564 to 955 395 to 1     Submitted on the opposite strand 395/449
(87 %)
6 diff
(98.7 %id)
CD366667 Alveolar Macrophage, lung .d 601 to 1287 705 to 19   AAA   687/687
(100 %)
3 diff
(99.6 %id)
CN414720 embryonic stem cells, DMSO-treated H9 cellline .d 676 to 1348 1 to 673   tiling clone,   673/673
(100 %)
1 diff
(99.9 %id)
AW938483 denis_drash .d 1069 to 1416 9 to 356   tiling clone,   348/370
(94 %)
3 diff
(99.2 %id)
R53843 placenta .d 1106 to 1463 1 to 359       359/359
(100 %)
4 diff
(98.9 %id)
BF799716 colon_ins .d 1293 to 1843 4 to 563   tiling clone,   560/575
(97 %)
6 diff
(99.0 %id)
AA411762   .d 1476 to 1763 1 to 288   tiling clone, Submitted on the opposite strand 288/288
(100 %)
0 diff
(100 %id)
DB190984 lung, tumor tissue .e 1 to 576 2 to 577 D14N tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
BM804110 eye, retinoblastoma .e 17 to 843 36 to 875 A13E A68V tiling clone,   840/1119
(75 %)
33 diff
(97.1 %id)
N78491 multiple sclerosis lesions .e 35 to 580 1 to 556 D14N R21A I22X D23I P24X ...     556/556
(100 %)
47 diff
(91.6 %id)
CN356182 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 38 to 515 1 to 478       478/478
(100 %)
1 diff
(99.8 %id)
BG329979 eye, retinoblastoma .e 260 to 736 1 to 479       479/989
(48 %)
7 diff
(99.3 %id)
CN356171 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .e 325 to 764 1 to 440   tiling clone,   440/440
(100 %)
3 diff
(99.4 %id)
N73650 multiple sclerosis lesions .e 1011 to 1535 532 to 1   tiling clone,   532/598
(88 %)
27 diff
(95.5 %id)
BM794577 stomach .f 1 to 543 1 to 546 exact tiling clone,   546/548
(99 %)
4 diff
(99.3 %id)
AV691180 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV684794 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV690181 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV692258 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV694446 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV697759 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV696493 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV697588 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV688014 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV685575 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV690021 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
AV692306 hepatocellular carcinoma Gene ATF5, variant not shown         This clone was ignored    
CB158479 Liver Gene ATF5, variant not shown         Suspected internal deletion, this clone was ignored    
AV653635 corresponding non cancerous liver tissue Gene ATF5, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV661646 corresponding non cancerous liver tissue Gene ATF5, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV651606 corresponding non cancerous liver tissue Gene ATF5, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BJ994358 hepatoblastoma Gene ATF5, variant not shown         Suspected internal deletion, this clone was ignored    
BP338926 Spleen Gene ATF5, variant not shown         Suspected internal deletion, this clone was ignored    
AK091985 Liver Gene ATF5, variant not shown       available from FLJ, This clone was ignored    
AW963238   Gene ATF5, variant not shown         Suspected internal deletion, this clone was ignored    
T32244 Liver Gene ATF5, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
N93059 lung Gene ATF5, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
W24692 lung Gene ATF5, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AA601609 breast Gene ATF5, variant not shown         Suspected internal deletion, this clone was ignored    
AA872311 2 pooled tumors (clear cell type), Kidney Gene ATF5, variant not shown       AAA Suspected internal deletion, this clone was ignored    
AI917595 colon, colon tumor, RER+ Gene ATF5, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BQ277745 ovary, teratocarcinoma, cell line Gene ATF5, variant not shown         This clone was ignored    
BU553249 ovary, teratocarcinoma, cell line Gene ATF5, variant not shown         This clone was ignored    
BU845299 ovary, teratocarcinoma, cell line Gene ATF5, variant not shown         This clone was ignored    
BU845613 ovary, teratocarcinoma, cell line Gene ATF5, variant not shown         This clone was ignored    
BU553858 ovary, teratocarcinoma, cell line Gene ATF5, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI